ScoreWhy is Medpace Holdings, Inc. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 48.42%
- Healthy long term growth as Net Sales has grown by an annual rate of 20.40% and Operating profit at 29.38%
- Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.05 times
2
The company has declared Positive results for the last 7 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 614.11 MM
- ROCE(HY) Highest at 89.38%
- NET SALES(Q) Highest at USD 603.31 MM
3
High Institutional Holdings at 94.92%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 3.73% over the previous quarter.
4
Market Beating performance in long term as well as near term
- Along with generating 81.11% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Medpace Holdings, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Medpace Holdings, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Medpace Holdings, Inc.
60.57%
0.77
65.90%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.40%
EBIT Growth (5y)
29.38%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.70
Sales to Capital Employed (avg)
3.87
Tax Ratio
13.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.92%
ROCE (avg)
105.06%
ROE (avg)
48.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
14.39
EV to EBIT
17.81
EV to EBITDA
16.73
EV to Capital Employed
46.20
EV to Sales
3.77
PEG Ratio
0.59
Dividend Yield
NA
ROCE (Latest)
259.48%
ROE (Latest)
70.14%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 614.11 MM
ROCE(HY)
Highest at 89.38%
NET SALES(Q)
Highest at USD 603.31 MM
RAW MATERIAL COST(Y)
Fallen by -3.4% (YoY
OPERATING PROFIT(Q)
Highest at USD 133.35 MM
-2What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 60.05 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.57 times
Here's what is working for Medpace Holdings, Inc.
Operating Cash Flow
Highest at USD 614.11 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 603.31 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD 133.35 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Raw Material Cost
Fallen by -3.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Medpace Holdings, Inc.
Debt-Equity Ratio
Highest at 60.05 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 6.57 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
